Patent · US Active

Albumin variants

US10696732B2 · kind B2 · utility

3Cited by
85References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2018
Grant dateJun 30, 2020
Priority date
Expiry dateMay 14, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.